Tumor lysis syndrome/tumor flare reaction in lenalidomide-treated chronic lymphocytic leukemia

被引：43

作者：

Moutouh-de Parseval, Laure A. ^{[1
]}

Weiss, Lilia ^{[1
]}

DeLap, Robert J. ^{[1
]}

Knight, Robert D. ^{[1
]}

Zeldis, Jerome B. ^{[1
]}

机构：

[1] Celgene Corp, Summit, NJ 07901 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 31期

关键词：

D O I：

10.1200/JCO.2007.14.2141

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：5047 / 5047

页数：1

共 6 条

[1] Flavopiridol administered using a pharmacologically derived schedule is associated with marked clinical efficacy in refractory, genetically high-risk chronic lymphocytic leukemia [J].

Byrd, John C. ;

Lin, Thomas S. ;

Dalton, James T. ;

Wu, Di ;

Phelps, Mitch A. ;

Fischer, Beth ;

Moran, Mollie ;

Blum, Kristie A. ;

Rovin, Brad ;

Brooker-McEldowney, Michelle ;

Broering, Sarah ;

Schaaf, Larry J. ;

Johnson, Amy J. ;

Lucas, David M. ;

Heerema, Nyla A. ;

Lozanski, Gerard ;

Young, Donn C. ;

Suarez, Jose-Ramon ;

Colevas, A. Dimitrios ;

Grever, Michael R. .

BLOOD, 2007, 109 (02) :399-404

[2] Clinical efficacy of lenalidomide in patients with relapsed or refractory chronic lymphocytic leukemia: Results of a phase II study [J].

Chanan-Khan, Asher ;

Miller, Kena C. ;

Musial, Laurie ;

Lawrence, David ;

Padmanabhan, Swaminathan ;

Takeshita, Kenichi ;

Porter, Carl W. ;

Goodrich, David W. ;

Bernstein, Zale P. ;

Wallace, Paul ;

Spaner, David ;

Mohr, Alice ;

Byrne, Catriona ;

Hernandez-Ilizaliturri, Francisco ;

Chrystal, Cynthia ;

Starostik, Petr ;

Czuczman, Myron S. .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (34) :5343-5349

[3]

FERRAJOLI A, 2007, HAEMATOLOGICA S, P92

[4]

FERRAJOLI A, 2006, BLOOD S, V108

[5]

Yang HH, 1999, AM J HEMATOL, V62, P247, DOI 10.1002/(SICI)1096-8652(199912)62:4<247::AID-AJH9>3.0.CO

[6]

2-T

← 1 →